Trinity Biotech Q1 EPADS $(0.15) Up From $(0.50) YoY, Sales $14.83M Down From $15.68M YoY
Portfolio Pulse from Benzinga Newsdesk
Trinity Biotech (NASDAQ:TRIB) reported Q1 losses of $(0.15) per share, a 69.6% improvement from $(0.50) per share YoY. However, sales decreased by 5.40% to $14.83 million from $15.68 million YoY.
July 06, 2023 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Trinity Biotech reported improved Q1 losses but a decrease in sales YoY.
While Trinity Biotech has managed to reduce its losses significantly, the decrease in sales could be a concern for investors. The mixed results may lead to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100